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Although the beneﬁts of pulmonary rehabilitation (PR) have been demonstrated in patients
with COPD, most studies suggest that short-term programs are insufﬁcient to maintain the
beneﬁts beyond a post-discharge period of 6 months to 1 year. We were interested to
evaluate the effects of an innovative maintenance intervention compared with a usual
after-care.
Forty moderate to severe COPD patients, who had just completed their ﬁrst inpatient PR,
were consecutively included in either a maintenance group (MG) or a standard after-care
group. The maintenance program was coordinated within a health-care network including
self-help associations, and offered weekly activities. We measured the 6-min walk distance
(6MWD), the quality of life using the St George Respiratory Questionnaire (SGRQ), the
dyspnea, the maximal workload and the health-care utilization. Data were collected at
respiratory clinic admission and discharge, and at 6- and 12-month visits after the PR.
After 12 months, we found statistically and clinically signiﬁcant differences in favor of the
MG in 6MWD (74m; pp0.01) and in the three domains of SGRQ: symptom (19%; pp0.01),
activity (27%; pp0.01) and impact (32%; pp0.01). The results showed no difference
between groups in dyspnea and maximal workload. We also found that the number of days
spent in hospital for respiratory disorders was signiﬁcantly lower in the MG after 12 months
(pp0.03).
The multidisciplinary management of COPD patients in the post-rehabilitation period
within a health-care network including self-help associations seems to be an effective
strategy for maintaining, and even improving, the beneﬁts of a ﬁrst initial structured
program.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
601 123; fax: +33 467 415 708.
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A maintenance intervention in a health-care network 557Introduction to the follow-up groups is based on the unpredictableInterest has arisen in strategies to maintain the beneﬁts of
pulmonary rehabilitation (PR) over time, such as repeated
courses of rehabilitation treatment1 or maintenance inter-
ventions: i.e., hospital consultations,2–8 phone support,9
nursing visits at home,10–12 activities in self-help groups.13
The beneﬁts of these interventions are too heterogeneous to
indicate the form a maintenance strategy should take or how
it should be applied. However, some key points have emerged.
The supervision of activities appears to be one key
element.3,4,13–15 Interaction with health-care providers who
shared information, built partnerships, and gave emotional
support also led to greater adherence to health recommen-
dations.16 Guell et al.13 reported that improvements in the
dyspnea score, 6-min walk distance (6MWD) and quality of life
(QoL) were maintained 18 months after discharge and
suggested that a speciﬁc maintenance program including a
self-help group was particularly effective. A maintenance
program that provides a socially supportive environment can
facilitate the adjustment process by encouraging adaptive
thoughts and behaviors. Peer support among patients with
other chronic diseases has consistently been reported as an
important factor in adherence to therapy.17,18 Moreover, the
World Health Organization noted that truly collaborative
follow-up is an effective means to ensure smooth coordina-
tion and greater partnership among health-care providers and
between these providers and patients.19 Last, when set
within a collaborative network,20 patient-run support groups
reinforce social supports and promote exchanges between
patients, encouraging them to take greater responsibility for
their own care.21
Therefore, this controlled pilot study was designed to
determine the 1-year effect of a multidisciplinary main-
tenance program after a ﬁrst inpatient PR. The program, run
in local patient self-help associations after PR, proposed
weekly activities that were coordinated within a regional
health-care network. The primary outcome measure was the
6MWD. The secondary outcome measures were QoL,
dyspnea, maximal workload and health-care utilization
assessments.
Methods
Subjects and experimental design
Patients with moderate to severe COPD22 were recruited
from three regional rehabilitation centers where they had
just beneﬁted from their ﬁrst PR program. Inclusion criteria
for the rehabilitation session were as follows: a post-
bronchodilator forced expiratory volume in 1 second
(FEV1)/forced vital capacity (FVC)o0.7 and an FEV1
30–79% predicted, no indication for home oxygen therapy,
and no exacerbation or hospitalization in the previous 2
months. Exclusion criteria were signiﬁcant medical or
psychiatric disturbances that would interfere with full
participation in the program. The patients participated in
the 20 sessions of the 4-week inpatient PR.23 Afterwards,
the patients were consecutively included in standard after-
care group (SG) or maintenance group (MG) after PR
discharge. The consecutive assignment of eligible patientsoccurrence of their domiciliation. The subjects assigned to
the SG were those who lived in towns without existing self-
help association. No information on the creation of a self-
help association in the coming year was given to the
patients. The study was approved by the medical ethics
committees of all three centers, and all patients provided
written informed consent.
Standard after-care group
The patients in this group had been given a letter on
discharge outlining the recommended home care rehabilita-
tion program. They then continued with their usual primary
care follow-up for 1 year.
Experimental maintenance group
On discharge, all patients in this group joined a regional
health-care network that included three local self-help
associations of patients who had ever completed a PR
program. Each local multidisciplinary team in the network
provided the similar 96 coordinated sessions. To ensure the
quality and the consistency of the maintenance program, all
professionals participated in a training on PR, during which
they were taught all components of the program as follows:
(a) individualized exercise training (3.5h/week; 72 sessions)
supervised by a teacher of adapted physical activities in a
town gymnasium including breathing exercises, interval
training (in circuit and in team sport—in line with the
patients interest’s), strength training, upper limb training
(with free weights, elastic bands), and endurance training
with nature walking at the ventilatory threshold24; (b) health
education provided alternatively by all professionals of the
health-care network (2 h/month; 12 sessions) in a municipal
conference room; and (c) psychosocial support (with discus-
sion group 1h/month; 12 sessions) supervised by a psychol-
ogist in the same room. The self-help associations could
obviously decide to add discretionary leisure activities desired
by members, such as museum visits, restaurant outings or
inter-group meetings. These groups were entirely run by the
patients. The self-help associations are federated in a larger
association—the healthcare network. They beneﬁt from
resources provided by the regional network ﬁnancing the 96
sessions supervised by the health professionals in the 1-year
maintenance program (for more information on the organiza-
tion of the health-care network, see www.airplusr.fr).
Assessments
All the patients were evaluated before and after PR, and 6
and 12 months after the completion of the PR. Utilization of
health-care resources was also assessed ﬁrst before and then
12 months after the PR. To ensure uniform assessments in
this multicentric study, the medical and scientiﬁc commit-
tee of the health-care network developed recommendations
for a standard protocol for instrument use and patient
assessment.
Primary outcome measure
6MWD. The 6MWD test was performed twice with more than
30min between tests to allow heart rate and dyspnea to
return to their initial rest values.25 Subjects were asked to
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G. Moullec et al.558walk at their own maximal pace along a perimeter of 30m.
No encouragement was given, and subjects were informed
each minute of the time remaining. A dyspnea score was
measured on a visual analog scale (VAS) before and at the
end of the test. We considered a difference of X54m as
clinically important.26
Secondary outcome measures
Quality of life. Disease-speciﬁc QoL was assessed by the
French version of St George Respiratory Questionnaire
(SGRQ). This validated 50-item questionnaire27,28 has been
widely used in patients with COPD.9,10,29–31 The SGRQ is
composed of three domains: symptoms, activities and
impacts. Scores range between 0 (no impairment) and 100
(worst possible health). A difference X4.0 is considered as
the minimum clinically important difference.32
The short version of the QoL questionnaire validated by the
World Health Organization (WHOQOL-Brief)33 was used as a
generic measure. The WHOQOL-Brief has 26 items that
assess the consequences of illness on daily life along six
domains: physical, psychological, social, environmental,
global QoL and health satisfaction. The scores were
calculated on a scale from the raw item scores, which range
from 4 to 20, with lower scores reﬂecting deteriorated QoL.
A six-item questionnaire with a VAS was administered to
measure the functional consequences of COPD on daily life.
Under each item, a single 10-cm horizontal line without
formal indications can be scored from ‘‘not at all’’ (0 cm) to
‘‘absolutely’’ (10 cm). This questionnaire includes six do-
mains on satisfaction concerning respiratory control beha-
vior, physical activity, sleep, fatigue, physical condition and
dyspnea. The physical condition item was validated by
previous research.34
Maximal exercise test. Maximal exercise test was per-
formed on a cycle ergometer following the individualized
protocol usually used in our laboratory35 and recommended
by the American Thoracic Society.36
Physical activity. The Voorrips provides a reliable and valid
method for classifying the activity level of older subjects as
high, medium or low with a score of 9 or more indicating a
low physical level, thus classifying the subject as being
sedentary.37
Health-care utilization. Utilization of health-care services
in the year before and after rehabilitation was assessed from
self-reports. The patients provided information on the
number of hospital admissions, the days spent in hospital,
the number of consultations with a general practitioner and
with a lung specialist, and the number of home visits by the
general practitioner. The information was checked by
inspection of the patient ﬁles.
Attendance. Attendance to the multidisciplinary follow-up
program was recorded for each participant in the MG by the
health providers during each session. Percent of compliance
for attendance was deﬁned as the number of sessions that
the participant attended, divided by the number of sessions
proposed in each self-help association, multiplied by 100.
Pulmonary function tests. According to European Respira-
tory Society guideline38 lung function measurements were
performed using a plethysmograph (V6200 Autobox; Sensor-
Medics, Yorba Linda, CA) to determine total lung capacity(TLC), FVC and FEV1. The Tiffeneau ratio (FEV1/FVC) was
then calculated.
Statistical analysis
Pre-(T1) and post-(T2) rehabilitation data were compared
with a repeated measure ANOVA for all eligible subjects.
Both experimental groups were also compared using
independent t-test for the continuous variable and Pearson
Chi square (w2) tests for the discrete variables.
Afterwards, the effects of the maintenance program were
evaluated in a two-way repeated measures ANCOVA (Time-
Group), with the corresponding baseline value of follow-up
program (T2) treated as a covariate. Data from 6-month (T3)
to 12-month assessments (T4) were used to evaluate the
changes of primary and secondary outcome measures over
time and the differences in these changes across both groups.
The effect sizes of the maintenance program were estimated
by the partial eta square (Z2P) for each outcome measure.
For the signiﬁcant TimeGroup interactions, group
differences at T2, T3 and T4 were examined with by
independent-sample t-tests at each time point. In these
follow-up analyses, mean differences, conﬁdence intervals
around this difference, and least signiﬁcant different (LSD)
Fisher tests were examined.
Because the health-care utilization’s data were not
normally distributed, we used (1) a Wilcoxon sign-rank test
to compare data 1 year before and after enrollment in the
PR program, and (2) a Mann–Whitney U test to compare data
between MG and SG. Signiﬁcance for all analyses was
accepted at pp0.05, and the approach was two sided.
Results
Initial PR program
Out of the 650 COPD patients rehabilitated during the last 2
years in our centers, only 50 patients were domiciled in our
region and had completed their ﬁrst PR program (Figure 1).
Therefore, they were eligible for the study. Of these, the 40
with complete discharge data who agreed to participate
were consecutively admitted to either the experimental MG
(n ¼ 14) or to a SG (n ¼ 26) for 1 year.
Table 1 summarizes selected descriptive characteristics
and changes after PR in all 40 eligible COPD patients.
Rehabilitation improved measures of exercise performance
(6MWD, maximal workload, _VO2max and workload at venti-
latory threshold) and QoL, according to the three domains of
SGRQ. There were no signiﬁcant differences at the time of
discharge in the subgroup analyses.
Follow-up period
At 1 year of individual follow-up, 13 subjects had not
completed the scheduled sessions of assessment (Figure 1).
In the SG, six patients had dropped out at the 6-month
point for the following reasons: three exacerbation crises,
one inpatient psychiatry admission, one death due to
cardiac failure and one infectious arm. At 1-year, further
four control subjects had dropped out because of acute
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40 participants 
14 assigned to experimental 
maintenance group 
26 assigned 
to standard after-care group 
1 died before 
6th-month visit
12 completed 
6th-month 
visit
T3 
T2 
T1 
20 completed 
6th-month 
visit
5 with missing data 
at 6-month
2 with missing data
at 6-month 
11 completed 
12th-month 
visit
16 completed 
12th-month 
visit
T4 
1 with missing data 
at 12-month 
4 with missing data 
at 12-month
650 patients referred  
50 fit study criteria
(had just benefited from their first PR) 
10 refused to 
participate
600 had ever 
benefited from a PR
Figure 1 Trial proﬁle. Notes: based on completion of all assessments; PR: pulmonary rehabilitation.
Table 1 Results before and after the initial pulmonary rehabilitation in the 40 eligible patients.
Admission (T1) Discharge (T2) Mean difference between
groups (95% CI)
a
Sex (male/female)
Group S 21/5 0.50
Group M 10/4
Age (year)
Group S 59.779.6 2.9 (2.8 to 9.1) 0.29y
Group M 62.977.4
Single/marital status
Group S 10/16 0.79
Group M 6/8
Body-mass index (kg/m2)
Group S 24.975.0 24.675.2 1.1 (2.2 to 4.4) 0.51
Group M 25.974.8 25.874.7
Pulmonary function
FEV1 (% predicted)
Group S 46.7719.2 46.8718.2 4.2 (7.3 to 15.6) 0.47
Group M 52.6716.4 49.3714.9
FEV1/FVC (%)
Group S 52.1715.4 51.7716.8 2.6 (6.3 to 11.6) 0.55
Group M 54.9710.7 54.2710.1
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Table 1 (continued )
Admission (T1) Discharge (T2) Mean difference between
groups (95% CI)
a
TLC (% predicted)
Group S 121.5718.3 122.5719.5 10.1 (21.8 to 1.6) 0.09
Group M 111.0718.8 112.7715.9
Six-min walking test
Distance (m)
Group S 401.97106.6 454.27102.6z 18.5 (46.8 to 83.7) 0.57
Group M 424.1794.5 468.8795.4z
Dyspnea (0–10)
Group S 5.572.3 5.172.7 0.4 (1.8 to 1.1) 0.60
Group M 4.972.5 4.972.4
Maximum ergocycle exercise
Maximal workload (W)
Group S 67.9732.6 77.9735.7z 0.2 (23.3 to 23.7) 0.99
Group M 71.1735.5 75.1741.6
VEmax (L/min)
Group S 47.9719.7 49.5720.2 1.5 (14.4 to 11.4) 0.82
Group M 46.7716.7 47.8717.1
_VO2max (mL/min/kg)
Group S 14.975.3 15.975.3z 0.6 (4.1 to 2.9) 0.74
Group M 14.374.1 15.475.7
Workload at ventilatory threshold (W)
Group S 42.0721.8 51.5720.4z 6.9 (8.7 to 22.5) 0.37
Group M 51.1725.0 56.2729.6z
SGRQ scores
Symptoms
Group S 65.7718.7 58.8719.7z 2.5 (9.1 to 0.1) 0.66
Group M 68.1715.5 61.6716.7z
Activities
Group S 71.2714.0 64.5722.8z 2.1 (0.1 to 9.7) 0.72
Group M 67.5716.4 64.6717.9z
Impacts
Group S 45.1717.0 35.9716.8z 4.3 (0.1 to 6.3) 0.42
Group M 40.4714.8 32.6715.6z
Notes: values are expressed as mean7S.D.; Group S: standard after-care group; Group M: maintenance group.
Signiﬁcance level of the Pearson w2.
yIndependent-samples t-test.
zpo0.05 (Fisher test).
G. Moullec et al.560exacerbation. In the MG, three patients were lost to follow-
up evaluation (two because of acute chest exacerbation
crises at 6-month, and one with myocardial aneurysm at 1
year). The discharge data for the 13 patients who did not
complete the follow-up evaluations were comparable across
the board to those of the 27 subjects who completed both
the 6- and 12-month assessments (Table 2).
The results of the patients who completed all assessment
are presented in Table 3. They presented a comparable level
of physical activity measured by the Voorrips in the year
before rehabilitation (p ¼ 0.28). The w2-test showed nodifference in the proportion of male to female patients
between subgroups (p ¼ 0.67).Primary outcome measure
The ANCOVA showed a signiﬁcant interaction effect for
6MWD (pp0.01) (Table 3). We observed a signiﬁcant
deterioration of distance at 6-month (pp0.03) and 12-
month visit (pp0.03) for the SG. For the MG, the distances
walked at 1 year were higher than at PR discharge (pp0.04).
After 1 year, the difference between groups exceeded the
ARTICLE IN PRESS
Table 2 Data for all recruited patients at discharge (T2) of the initial pulmonary rehabilitation.
Group S Group M Group S+M
Completed Withdrawn a Completed Withdrawn a Completed Withdrawn a
N 16 10 11 3 27 13
Age (year) 57.178.8 63.879.7 0.11 64.676.1 56.379.3 0.12 60.278.6 62.179.7 0.61
Body-mass index (kg/m2) 25.375.1 23.575.3 0.30 26.974.0 21.675.9 0.19 26.074.7 23.175.2 0.08
Pulmonary function
FEV (% predicted) 48.9716.0 43.4721.8 0.48 51.6711.7 40.7724.8 0.35 50.0714.2 42.8721.5 0.24
FEV/FVC (% predicted) 51.6719.0 51.9713.6 0.65 52.376.7 61.3718.6 0.35 51.9715.0 54.1714.6 0.57
TLC (% predicted) 121.6716.1 124.0724.8 0.71 114.9716.4 104.7713.6 0.27 118.8716.2 119.5723.8 0.89
Six-min walking test
Distance (m) 473.4781.9 420.07130.2 0.20 471.3789.1 459.77138.8 0.59 472.6783.2 429.97127.1 0.17
Dyspnea (0–10) 4.872.4 5.573.3 0.61 4.972.3 5.173.2 0.58 4.872.3 5.473.1 0.56
Maximal ergocycle exercise
Wmax (W) 81.4728.5 72.2746.1 0.37 78.3736.1 63.3766.6 0.31 80.1731.2 75.7740.5 0.75
VEmax (L/min) 49.9712.8 48.8730.3 0.36 49.2711.3 43.0730.4 0.40 49.6712.0 47.3729.8 0.22
_VO2max (mL/min/kg)
16.374.1 15.477.3 0.53 15.475.7 15.376.6 0.86 15.974.7 15.476.9 0.54
Wthreshold (W) 51.0716.6 52.4727.8 0.76 57.8724.2 50.3751.9 0.40 53.8719.9 50.5727.2 0.67
SGRQ scores
Symptoms 61.5721.2 54.4717.0 0.43 59.0717.7 71.477.9 0.31 60.5719.5 58.4716.8 0.78
Activities 63.5717.4 66.0730.5 0.56 62.3718.9 73.0712.8 0.35 63.0717.8 67.7727.8 0.29
Impacts 34.8714.4 37.7720.7 0.60 29.6712.7 43.5723.2 0.31 32.7713.7 39.1720.3 0.26
Notes: values are expressed as mean7S.D.; Group S: standard after-care group; and Group M: maintenance group.
Independent-samples t-test.
A maintenance intervention in a health-care network 561minimum clinically important difference of 54m (75.8m;
pp0.01) (Table 3). For a comparable VAS dyspnea score
between groups at the end of exercise, the MG walked thus
75.8m farther than the SG at the 12-month visit.Secondary outcome measures
We observed a signiﬁcant clinically difference between
groups for symptoms (pp0.01), activities (pp0.01) and
impacts domain of SGRQ (pp0.01), 1 year after completion
of PR (Table 3). In addition, the score in the MG improved
between 6-month and 12-month for symptoms (pp0.02) and
from PR discharge to 6-month for activities (pp0.01) and
impacts (pp0.02).
The MG showed improvement in the scores of the physical
domain (of WHOQOL-Brief), with higher scores at 6-month
(pp0.03) and 1 year (pp0.04) compared with PR admission
values. Also, subgroup analyses revealed a signiﬁcant
difference after 6 months (pp0.05) and 1 year (pp0.01)
with higher scores for the MG. Similarly, ANCOVA indicated
an interaction effect for the perceived physical condition
domain (of VAS) (pp0.02). Scores improved between PR
discharge and 6-month (pp0.01) and remained higher at 12
month (pp0.01) for the MG compared with the SG.
No interaction effect was found for the general’s QoL,
psychological, social, environmental and health satisfaction
domains of WHOQOL-Brief.
The post-hoc test indicated a decline from discharge to 6-
month visit for theWmax of the SG (pp0.02). The MG showed
higher Wmax values at 6-month (pp0.04) and 1 year(pp0.05) than the workload developed at baseline, before
the completion of PR (Table 3). Last, the _VO2max values were
maintained in the MG and declined in the SG after PR
discharge.
There were no signiﬁcant differences between the MG
and the SG in measures of lung function over the follow-up
period.
After 1 year of follow-up, the total Voorrips score
improved signiﬁcantly for the MG (Table 3), from a low to
a moderate level of daily physical activity. On the other
hand, the SG did not show any signiﬁcant change at the
12-month visit, with lower scores than MG (pp0.01).
The 11 subjects of the MG who completed all follow-up
measures attended on average 65.8716.0 (68.6%) out of a
maximum of 96 sessions.
Regarding health-care utilization, the number of days
spent in hospital for respiratory causes signiﬁcantly differed
(pp0.03) between groups after 1 year (Table 4). Also, in the
SG, there were fewer home visits by a general practitioner
(pp0.04) in the 12 months following the PR than in the year
before rehabilitation.Discussion
This study indicates that a 1-year maintenance program,
after the completion of the PR, within a health-care
network including patient self-help associations is a feasible
approach to signiﬁcantly improve functional exercise capa-
city, QoL and health-care utilization variables compared
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Table 3 Results in patients who completed all follow-up evaluations.
Outcome measure Discharge (T2) D (95% CI)# a 6-month (T3) D (95%CI) a 12-month (T4) D (95%CI) a F(3.75) Z2P
Sex (male/female)
Group S 12/4 0.67
Group M 9/2
Pulmonary function
FEV1 (L)
Group S 1.3870.49 0.1 (0.2 to 0.9) 0.49 1.1870.43 1.2570.38
Group M 1.4370.33 1.3170.45 1.3170.40
Six-minute walk
Distance (m)
Group S 473.4781.9 22.6 (61.2 to 16.0) 0.24 435.8778.9y 74.2 37.7–110.5) 0.01 436.3782.1y 75.8 (32.0–119.6) 0.01 10.58 0.31
Group M 471.3789.1 508.4768.9 510.6780.2y
Dyspnea (0–10)
Group S 4.872.4 0.7 (1.1 to 2.4) 0.44 4.972.0 5.472.2
Group M 4.972.3 5.572.0 6.372.2
Maximum ergocycle exercise
Maximal workload (W)
Group S 81.4728.5 9.6 (22.6 to 3.4) 0.14 69.9726.8y 19.1 (2.1–36.1) 0.03 75.3723.3 13.44 (1.4 to 28.3) 0.07 4.05 0.15
Group M 78.3736.1 86.5744.8 86.1741.3
VEmax (L/min)
Group S 49.9712.8 2.1 (8.4 to 4.3) 0.51 44.7712.3 46.0710.7
Group M 49.2711.3 47.3717.5 47.2716.7
_VO2max (mL/min/kg)
Group S 16.374.1 0.5 (2.8 to 1.8) 0.66 14.673.5y 3.8 (1.2–6.4) 0.01 14.474.0y 2.4 (0.3 to 5.1) 0.08 5.23 0.18
Group M 15.475.7 17.776.7,y 16.275.6
Quality of life measures
SGRQ (MCID ¼ 4.0)
Symptom
Group S 61.5721.2 0.1 (11.0 to 9.5) 0.88 64.5715.7 6.7 (16.2 to 2.7) 0.15 65.3717.4 18.5 (30.9 to 6.2) 0.01 6.86 0.22
Group M 59.0717.7 56.2717.6 45.578.6,y,z
Activity
Group S 63.5717.5 5.6 (3.7 to 14.8) 0.22 67.3718.7 20.2 (33.4 to 7.1) 0.01 73.7712.9y 27.0 (40.0 to 14.0) 0.01 9.69 0.29
Group M 62.3718.9 46.3722.1,y 46.2723.6,y
Impact
Group S 34.7714.4 2.2 (4.3 to 8.6) 0.49 40.6720.3y 17.0 (28.1 to 5.8) 0.01 50.2714.1y 32.4 (42.0 to 22.8) 0.01 21.68 0.47
Group M 29.6712.8 19.6710.7,y 16.079.3,y
WHOQOL-BRIEF
Physical
Group S 10.572.4 0.8 (0.5 to 2.1) 0.21 10.472.8 2.2 (0.4–4.0) 0.02 9.472.2 3.4 (1.4–5.4) 0.01 7.15 0.26
Group M 12.472.6 13.572.0 13.471.9
Psychological
Group S 13.272.0 0.6 (0.9 to 2.1) 0.43 13.771.7 12.672.5
Group M 14.471.9 15.572.3 15.272.1
G
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Social
Group S 14.871.4 0.2 (1.2 to 1.6) 0.79 14.172.3 14.673.4
Group M 14.872.5 15.072.2 14.372.5
Environment
Group S 13.671.3 0.5 (0.7 to 1.6) 0.41 13.571.9 13.071.5
Group M 14.671.9 15.771.9 15.471.4
General’s quality of life
Group S 12.372.7 0.5 (1.6 to 2.7) 0.60 12.074.2 11.774.0
Group M 13.173.1 15.672.2 15.372.4
Health satisfaction
Group S 10.773.9 2.1 (4.6 to 0.4) 0.10 10.773.1 9.774.0
Group M 11.674.2 13.173.1 12.573.8
VAS
Respiratory control
Group S 4.972.8 1.1 (1.0 to 3.2) 0.30 4.272.8 3.872.7
Group M 6.472.3 6.472.2 6.772.4
Physical activity
Group S 4.072.4 1.7 (0.5 to 3.9) 0.12 4.372.8 4.173.2
Group M 6.172.4 7.272.1 7.171.1
Sleep
Group S 5.472.9 0.3 (1.5 to 2.2) 0.70 5.672.6 4.572.8
Group M 6.472.4 6.972.7 6.872.0
Fatigue
Group S 5.772.5 0.8 (3.2 to 1.7) 0.51 5.473.2 4.973.0
Group M 4.672.9 4.872.4 5.672.7
Physical condition
Group S 4.172.6 0.6 (2.8 to 1.5) 0.54 4.272.5 1.5 (0.3 to 3.4) 0.10 3.272.8 2.7 (0.6–4.7) 0.01 6.89 0.26
Group M 4.272.6 6.472.0,y 6.672.1,y
Dyspnea
Group S 2.772.3 0.1 (1.3 to 1.1) 0.86 3.573.5 4.073.0
Group M 1.771.0 2.671.5 1.371.2z
Voorrips
Group S 4.273.6 1.6 (1.4–4.7) 0.28 5.174.9 6.9 (2.7–11.2) 0.01
Group M 5.874.0 12.075.8
Notes: values are expressed as mean7S.D.; PR: pulmonary rehabilitation; Group S: standard after-care group; Group M: maintenance group; D (95% CI): difference between maintenance
and control group adjusted for T2 (# for T1) (95% conﬁdence interval); a: signiﬁcance level of the Pearson w2; F(3.75): two-way repeated measures ANCOVA (TimeGroup); and Z2P: effect
size estimated by the partial eta square.
po0.05 (Fisher test) vs. admission (T1).
ypo0.05 vs. discharge (T2).
zpo0.05 vs. 6 months (T3).
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Table 4 Results of self-reported health-care utilization
over the 1 year before and after the inpatient pulmonary
rehabilitation.#
One-year pre-
rehabilitation
One-year post-
rehabilitation
Hospital days
Respiratory causes
Group S 2.776.2 6.4714.5y
Group M 3.074.0 0.0
All causes
Group S 5.6712.2 7.9716.1
Group M 3.575.2 1.573.4
Consultations with general practitioner
Group S 7.774.7 7.874.6
Group M 6.173.7 6.273.2
General practitioner’s home visits
Group S 1.775.1 0.973.0
Group M 0.0 0.0
Consultations with lung specialist
Group S 3.372.8 2.570.4
Group M 4.776.6 3.875.6
Notes: Group S: standard after-care group and Group M:
maintenance group.
#In patients who completed all follow-up evaluations.
ypo0.05 (Mann–Withney test).
po0.05 (Wilcoxon test).
G. Moullec et al.564with standard after-care. Although some studies advocating
maintenance follow-up programs4,7,8,12–14,29,39 have re-
ported maintained beneﬁts of PR as the best result, ours is
the ﬁrst to indicate actual improvement after a 12-month
maintenance program.Limitations of the study
We see several important implications of our pilot study.
Before discussing them, we consider some potential limita-
tions. Without a randomized controlled design, the beneﬁts of
the maintenance program cannot be concluded in this study.
Other factors may have contributed to change. Further
randomized controlled clinical trials are needed to conﬁrm
these hypotheses. This potential bias is, however, minimized
by the consecutive assignment of patients to SG or MG after
PR discharge in function of unpredictable occurrence of their
domiciliation. Each patient was included in one of the two
groups according to the presence of a local self-help
association. The low number of participants in each group
also merits comment. While 650 patients had completed a PR
over the 2-year period of inclusion, only 40 patients ﬁt study
criteria and were enrolled in the follow-up evaluation. Note
that our follow-up study is the ﬁrst to impose the participation
in a ﬁrst PR as an inclusion criterion. Then, this criterion
improves the internal validity of our study and reduces the
potential weakness of the sample size which parallels those of
previous follow-up studies with COPD.39–42Standard-after-care group
The statistically signiﬁcant decline in 6MWD occurred
earlier, after PR discharge, than in most studies.8,40,43–47
These studies consistently demonstrated that beneﬁts in
exercise tolerance were well maintained for a period of up
to 12 months. One reason for this discrepancy is that our
patients had beneﬁted from their ﬁrst PR and had thus not
incorporated all of the recommendations into their daily
living activities. The higher number of drop-outs in the SG
due to exacerbation increased physical deconditioning.
Paradoxically, the QoL beneﬁts were signiﬁcantly main-
tained. As demonstrated by previous studies8,29,41,48 the
beneﬁts in functional dimensions of QoL, like symptoms
(SGRQ), physical condition (VAS), and physical domains
(WHOQOL-Brief), were sustained for 1 year. The patients
have rediscovered their own abilities to tolerate exercise in
their usual environment. They better controlled their
dyspnea during daily routines.49 The affective theory of
Brown et al.50 predicts that functional self-perceptions,
which are related to the way that people appraise their
particular abilities, are less likely to be affected after life
events. Thus, patient avoided to recognize objective
deterioration in exercise performance. The group showed
a doubling of hospital days between the year before and
after inpatient PR session, and a signiﬁcant decrease of
exercise participation.51
The impacts domain of SGRQ, which covers opinion on
disease, panic and pessimism about disease, conversely
showed deterioration at 1 year. Our results support those of
Grifﬁths et al.29 who noted that the anxiety score (HAD
scale), the emotional domain (CRDQ) and the social,
emotional and mental domains of SF-36 showed improve-
ments made during the PR period that were less robust than
the functional ones, 12 months after being discharged. The
failure to maintain the emotional dimensions can be
explained by these global self-perceptions which, based on
affective beliefs, are more exposed to ﬂuctuations caused
by mood variations and daily life events.50 Therefore,
further intensive PR sessions could be needed to inﬂuence
substantively these emotional self-perceptions, and perhaps
the status of COPD on daily life.Maintenance group
The improvement in exercise tolerance and the overall
ratings of QoL in the MG, with statistically and clinically
signiﬁcant differences between groups, 1 year after PR
discharge, indicates the effectiveness of the maintenance
strategy. In terms of health-care utilization, the number of
days spent in hospital for respiratory disorders was
signiﬁcantly lower in the MG at 1 year. In fact, no admission
for respiratory reasons was noted in the MG during the post-
rehabilitation year. Two major explanations can be the
interdisciplinary approach to managing chronic disease and
the social support found in the self-help associations of a
health-care network.
First, the multidisciplinary approach of the maintenance
program seems to be effective. The complementary and
coordinated services and the collaboration of practitioners,
including the lung specialist, contributed to a coherent
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A maintenance intervention in a health-care network 565strategy for efﬁciently responding to the chronic nature of
the COPD, its systemic manifestations, and the unpredict-
ability of symptoms. Monthly educational sessions asso-
ciated with weekly exercise training enhanced practical
knowledge and behavior.52 The correspondence between the
technical language of medicine and what the patients felt
and imagined about their disease was even strengthened.
This reduction of semantic discrepancy facilitates the long-
term maintenance of healthy behaviors and could be a
potent source of motivation for patients to become active
and responsible participants in their own care.19 The
knowledge of regularity and the enhancement of motivation
in health behaviors may explain the continuing improvement
in exercise performance and QoL over the entire post-
rehabilitation year. In addition, a monthly psychosocial
group session led by a clinical psychologist would be an
opportunity for the patients to integrate the functional
progress made during exercise sessions and to improve
overall well-being and self-esteem.53
Secondly, belonging to a health-care network with a self-
help association, after PR discharge, contributed to the
feeling of being included in a community.20,54 The high
adherence with the maintenance program (42/3 of
sessions), observed in the patients who completed all
scheduled follow-up evaluations, illustrates this active
engagement in the care process. The community is likely
to respond to psychological isolation with coordinated
activities and collective projects, thereby decreasing
depressive, morbid thoughts.55 The social support of other
COPD participants and the greater partnership with health
professionals might encourage individual initiative and
attempts to reduce emotional reactions and choose adapted
behaviors. The patients viewed themselves as active
partners in the treatment process.19
To conclude, this pilot study suggests that, for COPD
patients, a combination of services coordinated within self-
help associations federated in a collaborative health-care
network is an innovative and efﬁcient maintenance pro-
gram, not only for maintaining but also for improving the
beneﬁts of a ﬁrst successful inpatient PR. Note that the
situation may be complicated in the future with not only the
low number of PR centers, but also by a poor turnover of
patients. Thus, this feasible maintenance program which
increases the collaboration among health providers would
not be a substitute of PR but might allow to extend the
period between two intensive PR sessions56 and so to
facilitate the inclusion of new patients in PR centers.Conﬂict of interest statement
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